Gene Environment interactions in Mental health trajectories of Youth

Acronym

Youth-GEMs

Description of the granted funding

Youth mental health is heavily burdened, with life-long enduring impact on European citizens and societies. Trajectories of mental health and illness in young people are assumed to be determined by interplay between genetic, epigenetic, and environmental risk impacting during development. However, direct evidence for this is sparse and scientific progress is challenged. We recently initiated substantial advances enabling us to create necessary breakthroughs at the most pressing needs and challenges. Aiming to significantly reduce mental suffering and illness among European youth within the next 5-10 years, we will provide 1) the world?s first, evidence-based knowledge base of functional (epi)genomics of the developing post-natal human brain in direct relation to developmental trajectories of trans-syndromal phenotypes of mental illness, providing improved risk markers and actionable biological targets, 2) reliable predictive models, while identifying gene-environment interplay, as well as actionable markers of trajectories of mental (ill)health in young people through the use of Artificial Intelligence (AI)-based and inference-based analyses of unprecedented sets of longitudinal general population datasets, 3) the first comprehensive, validated set of evidence-based behavioural, environmental, biological, and psychological-informed instruments for the robust quantitative clinical assessment of mental health for help-seeking young people aged 12-24 years, harmonised across European clinical settings, and 4) youth- and clinician-empowering AI-driven instruments for early (self)detection, prediction and monitoring of mental ill-health trajectories in youth. Our multidisciplinary consortium is uniquely equipped and positioned to enforce the necessary breakthroughs for significant reduction of mental illness and suffering of young people, and to translate our findings into clinical innovation and life-long impact in Europe and beyond.
Show more

Starting year

2022

End year

2027

Granted funding

666 945 €
Participant
UNIVERSITY COLLEGE LONDON (UK)
Participant
MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV (DE)
400 000 €
Participant
KLINIKA ZA NEUROLOGIJU I PSIHIJATRIJU ZA DECU I OMLADINU (RS)
293 936 €
Participant
Stichting Hogeschool Utrecht (NL)
412 950 €
Participant
SVEUCILISTE U SPLITU MEDICINSKI FAKULTET (HR)
314 718 €
Participant
FUNDACIO CENTRE DE REGULACIO GENOMICA (ES)
175 000 €
Participant
FUNDACION PARA LA INVESTIGACION BIOMEDICA DEL HOSPITAL GREGORIO MARANON (ES)
673 975 €
Participant
AB.ACUS SRL (IT)
360 625 €
Participant
THE UNIVERSITY OF EXETER (UK)
Participant
ROYAL COLLEGE OF SURGEONS IN IRELAND (IE)
449 694 €
Participant
THE UNIVERSITY OF QUEENSLAND (AU)
Participant
TARTU ULIKOOL (EE)
347 000 €
Participant
UNIVERSITAIR MEDISCH CENTRUM UTRECHT (NL)
838 500 €
Participant
UNIVERSITEIT MAASTRICHT (NL)
2 466 512 €
Coordinator
CARDIFF UNIVERSITY (UK)
Participant
KING'S COLLEGE LONDON (UK)
Participant
UNIVERSITAT DE BARCELONA (ES)
708 125 €
Participant

Amount granted

8 107 980 €

Funder

European Union

Funding instrument

HORIZON Research and Innovation Actions

Framework programme

Horizon Europe (HORIZON)

Call

Programme part
Health (11673)
Health throughout the Life Course (11689)
Topic
Towards a molecular and neurobiological understanding of mental health and mental illness for the benefit of citizens and patients (HORIZON-HLTH-2021-STAYHLTH-01-02)
Call ID
HORIZON-HLTH-2021-STAYHLTH-01

Other information

Funding decision number

101057182

Identified topics

ageing, health